Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
- Application ID: EP14188054
- Status: █ EXAMINATION IN PROGRESS
This EP application has the IPC class G01 (MEASURING; TESTING). Roche Diagnostics GmbH is specialized in G01. Roche Diagnostics GmbH is specialised in G01 (MEASURING; TESTING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
- 19.07.2010 - Priority Date (EP 20100170008)
- 14.01.2015 - Publication A1 (EP2824457)